China Sxt Pharmaceuticals Stock Price Prediction
| SXTC Stock | USD 1.17 0.23 16.43% |
Oversold Vs Overbought
46
Oversold | Overbought |
China SXT Pharmaceuticals stock price prediction is an act of determining the future value of China SXT shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of China SXT's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of China SXT and does not consider all of the tangible or intangible factors available from China SXT's fundamental data. We analyze noise-free headlines and recent hype associated with China SXT Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting China SXT's stock price prediction:Quarterly Earnings Growth 0.426 | Quarterly Revenue Growth (0.22) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of China SXT based on different types of headlines from major news networks to social media. The China stock price prediction module provides an analysis of price elasticity to changes in media outlook on China SXT over a specific investment horizon. Using China SXT hype-based prediction, you can estimate the value of China SXT Pharmaceuticals from the perspective of China SXT response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in China SXT. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in China SXT to buy its stock at a price that has no basis in reality. In that case, they are not buying China because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
China SXT after-hype prediction price | USD 1.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
China |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of China SXT's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
China SXT After-Hype Price Prediction Density Analysis
As far as predicting the price of China SXT at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in China SXT or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of China SXT, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
China SXT Estimiated After-Hype Price Volatility
In the context of predicting China SXT's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on China SXT's historical news coverage. China SXT's after-hype downside and upside margins for the prediction period are 0.06 and 6.98, respectively. We have considered China SXT's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
China SXT is extremely dangerous at this time. Analysis and calculation of next after-hype price of China SXT Pharmaceuticals is based on 3 months time horizon.
China SXT Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as China SXT is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading China SXT backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with China SXT, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.45 | 6.04 | 0.05 | 0.06 | 5 Events / Month | 7 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.17 | 1.22 | 4.27 |
|
China SXT Hype Timeline
China SXT Pharmaceuticals is at this time traded for 1.17. The entity has historical hype elasticity of 0.05, and average elasticity to hype of competition of 0.06. China is anticipated to increase in value after the next headline, with the price projected to jump to 1.22 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 4.27%, whereas the daily expected return is at this time at -0.45%. The volatility of related hype on China SXT is about 4851.02%, with the expected price after the next announcement by competition of 1.23. China SXT Pharmaceuticals currently holds about 15.52 M in cash with (80.76 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow. Given the investment horizon of 90 days the next anticipated press release will be in about 5 days. Check out China SXT Basic Forecasting Models to cross-verify your projections.China SXT Related Hype Analysis
Having access to credible news sources related to China SXT's direct competition is more important than ever and may enhance your ability to predict China SXT's future price movements. Getting to know how China SXT's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how China SXT may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BFRI | Biofrontera | 0.15 | 6 per month | 9.76 | 0.01 | 24.68 | (18.71) | 72.04 | |
| SHPH | Shuttle Pharmaceuticals | 0.02 | 6 per month | 0.00 | (0.03) | 6.98 | (5.00) | 38.63 | |
| AKAN | Akanda Corp | 0.01 | 10 per month | 0.00 | (0.15) | 16.13 | (25.00) | 47.92 | |
| CPHI | China Pharma Holdings | 0.35 | 8 per month | 0.00 | (0.05) | 10.81 | (9.09) | 33.40 | |
| TKNO | Alpha Teknova | 0.14 | 5 per month | 0.00 | (0.1) | 7.38 | (8.78) | 28.78 | |
| CYTH | Cyclo Therapeutics | (0.02) | 5 per month | 0.00 | (0.03) | 6.45 | (7.57) | 38.84 | |
| PTPI | Petros Pharmaceuticals | 0.11 | 8 per month | 0.00 | (0.1) | 10.00 | (8.79) | 49.94 | |
| LFCR | Lifecore Biomedical | 0.75 | 7 per month | 0.00 | (0.01) | 9.04 | (4.88) | 46.34 | |
| ORGO | Organogenesis Holdings | (0.17) | 7 per month | 0.00 | (0.14) | 5.34 | (5.44) | 25.39 | |
| AQST | Aquestive Therapeutics | (0.09) | 9 per month | 4.40 | 0.12 | 14.06 | (5.70) | 35.59 |
China SXT Additional Predictive Modules
Most predictive techniques to examine China price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for China using various technical indicators. When you analyze China charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About China SXT Predictive Indicators
The successful prediction of China SXT stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as China SXT Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of China SXT based on analysis of China SXT hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to China SXT's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to China SXT's related companies. | 2023 | 2024 (projected) | Dividend Yield | 6.35E-4 | 5.64E-4 | Price To Sales Ratio | 4.3 | 4.08 |
Story Coverage note for China SXT
The number of cover stories for China SXT depends on current market conditions and China SXT's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that China SXT is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about China SXT's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
China SXT Short Properties
China SXT's future price predictability will typically decrease when China SXT's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of China SXT Pharmaceuticals often depends not only on the future outlook of the potential China SXT's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. China SXT's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1 M | |
| Cash And Short Term Investments | 17.4 M |
Check out China SXT Basic Forecasting Models to cross-verify your projections. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for China Stock analysis
When running China SXT's price analysis, check to measure China SXT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China SXT is operating at the current time. Most of China SXT's value examination focuses on studying past and present price action to predict the probability of China SXT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China SXT's price. Additionally, you may evaluate how the addition of China SXT to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is China SXT's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China SXT. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China SXT listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.426 | Earnings Share (22.22) | Revenue Per Share 3.65 | Quarterly Revenue Growth (0.22) | Return On Assets (0.46) |
The market value of China SXT Pharmaceuticals is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China SXT's value that differs from its market value or its book value, called intrinsic value, which is China SXT's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China SXT's market value can be influenced by many factors that don't directly affect China SXT's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China SXT's value and its price as these two are different measures arrived at by different means. Investors typically determine if China SXT is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China SXT's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.